A detailed history of Yousif Capital Management, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 6,249 shares of BIO stock, worth $2.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,249
Previous 2,574 142.77%
Holding current value
$2.1 Million
Previous $702,000 197.72%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$263.97 - $344.64 $970,089 - $1.27 Million
3,675 Added 142.77%
6,249 $2.09 Million
Q2 2024

Jul 31, 2024

SELL
$268.26 - $339.48 $17,973 - $22,745
-67 Reduced 2.54%
2,574 $702,000
Q1 2024

Apr 26, 2024

SELL
$304.11 - $351.99 $40,750 - $47,166
-134 Reduced 4.83%
2,641 $913,000
Q4 2023

Feb 01, 2024

BUY
$269.37 - $365.04 $13,737 - $18,617
51 Added 1.87%
2,775 $896,000
Q3 2023

Oct 30, 2023

SELL
$350.25 - $422.63 $42,730 - $51,560
-122 Reduced 4.29%
2,724 $976,000
Q2 2023

Aug 02, 2023

BUY
$359.49 - $486.4 $52,126 - $70,528
145 Added 5.37%
2,846 $1.08 Million
Q1 2023

May 02, 2023

SELL
$418.69 - $503.0 $86,668 - $104,121
-207 Reduced 7.12%
2,701 $1.29 Million
Q4 2022

Jan 09, 2023

BUY
$351.71 - $456.01 $48,887 - $63,385
139 Added 5.02%
2,908 $0
Q3 2022

Nov 04, 2022

SELL
$412.59 - $563.26 $11,965 - $16,334
-29 Reduced 1.04%
2,769 $1.16 Million
Q2 2022

Aug 01, 2022

SELL
$463.67 - $597.16 $91,342 - $117,640
-197 Reduced 6.58%
2,798 $1.39 Million
Q1 2022

May 12, 2022

BUY
$524.57 - $735.42 $5,245 - $7,354
10 Added 0.34%
2,995 $1.69 Million
Q4 2021

Jan 31, 2022

BUY
$708.84 - $794.68 $2.12 Million - $2.37 Million
2,985 New
2,985 $2.26 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.28B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.